Europe - Euronext Oslo - OSL:LIFE - NO0013355859 - Common Stock
The current stock price of LIFE.OL is 1.745 NOK. In the past month the price decreased by -63.26%. In the past year, price decreased by -86.31%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.02 | 104.54B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.61 | 50.17B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 15.84 | 22.57B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.62 | 22.26B | ||
| BIM.PA | BIOMERIEUX | 28.63 | 13.08B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 140.74 | 4.23B | ||
| DIA.MI | DIASORIN SPA | 20.98 | 3.89B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.98 | 3.60B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.62 | 1.29B | ||
| ELN.MI | EL.EN. SPA | 21.66 | 1.11B | ||
| DRW8.DE | DRAEGERWERK AG | 8.62 | 1.04B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 23.25 | 959.79M |
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 28 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
LIFECARE ASA
Ytrebygdsvegen 215
Bergen HORDALAND NO
Employees: 32
Phone: 4740059040
Lifecare ASA engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland and currently employs 28 full-time employees. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
The current stock price of LIFE.OL is 1.745 NOK. The price decreased by -46.47% in the last trading session.
LIFE.OL does not pay a dividend.
LIFE.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
LIFECARE ASA (LIFE.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-16.64).
You can find the ownership structure of LIFECARE ASA (LIFE.OL) on the Ownership tab.
ChartMill assigns a fundamental rating of 3 / 10 to LIFE.OL. LIFE.OL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months LIFE.OL reported a non-GAAP Earnings per Share(EPS) of -16.64. The EPS decreased by -40.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -93.35% | ||
| ROE | -124.42% | ||
| Debt/Equity | 0.12 |
null analysts have analysed LIFE.OL and the average price target is 36.72 NOK. This implies a price increase of 2004.3% is expected in the next year compared to the current price of 1.745.
For the next year, analysts expect an EPS growth of 8.12% and a revenue growth -75% for LIFE.OL